1. Home
  2. Labeler Index
  3. Akebia Therapeutics, Inc.
  4. 59922-631
  5. Product Images: Auryxia

Product Images Auryxia

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Auryxia NDC 59922-631 by Akebia Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Ferric Citrate Structure - keryx figure 1

Ferric Citrate Structure - keryx figure 1

This text provides two equations with two unknown variables, x and y. The first equation states that x is equal to 0.70 minus 0.87, and the second equation states that y is equal to 19 minus 33. These equations could be solved using algebra to find numerical values for x and y.*

Figure 1: Serum Phosphorus Control over 52 Weeks - keryx figure 2

Figure 1: Serum Phosphorus Control over 52 Weeks - keryx figure 2

This seems to be a table or some sort of data analysis. It shows the mean serum phosphorus levels in mg/dL for different study time periods (active-controlled periods) for a substance called Ferric Gtrate. However, the formatting of the text is not very clear, making it difficult to interpret accurately.*

Bottle Label - keryx figure 3

Bottle Label - keryx figure 3

Each tablet of Auryxia contains 210 mg of ferric iron as ferric citrate. It is advised to see the package insert for dosage information before use. The tablet is stored at a temperature range of 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit) with excursions up to 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit) and should be protected from moisture. The product should be kept away from the reach of children as accidental overdose of iron-containing products can be fatal for children under 6. In case of an accidental overdose, contact a doctor or a poison control center immediately. The product is manufactured for KERYX BIOPHARMACEUTICALS, INC., a wholly-owned subsidiary of Akebia Therapeutics, Inc., based in Cambridge, MA 02142. FD&C Yellow No. 6 is included in the product, and the National Drug Code for this product is 59922-631-01 for RX ONLY use.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.